儿童、青少年及年轻成人肝窦阻塞综合征的诊断、分级与治疗推荐:国际专家立场声明
该国际专家立场声明由多学科专家组于2019年2月在美国德克萨斯大学MD安德森癌症中心会议评估证据,推荐全球采用EBMT儿童肝窦阻塞综合征诊断指南并给出实施指导,提出按年龄器官特异性毒性标准辅助严重度分级,并给出预防和治疗考量。
要点
- 不推荐肝活检、门静脉楔压及多普勒超声门静脉血流反向用于儿童肝窦阻塞综合征的常规诊断。
- 肝大定义为锁骨中线肝长度绝对增加至少1 cm;无基线时定义为超过同龄正常值2个标准差。
- 腹水按有无及量分为轻度(肝、脾或盆腔极少量液体)、中度(液体<1 cm)和重度(三个区域均有液体且至少两个区域液体>1 cm)。
诊断标准与关键数值
- 肝活检、门静脉楔压及多普勒超声门静脉血流反向不应用于儿童、青少年及年轻成人肝窦阻塞综合征的常规诊断。
- 血小板输注无效可定义为至少连续两次ABO相容新鲜血小板输注后校正计数增量小于5000-7500。
- 肝大最好定义为锁骨中线肝长度绝对增加至少1 cm;若无基线测量,肝大定义为超过同龄正常值2个标准差以上。
- 腹水存在及量分为轻度(肝、脾或盆腔极少量液体)、中度(液体<1 cm)或重度(三个区域均有液体且至少两个区域液体>1 cm)。
临床应用与阅片要点
- 推荐全球采用EBMT提出的儿童肝窦阻塞综合征诊断指南,并参照本声明提供的实施指导在各中心间标准化。
- 严重度分级可辅助使用按年龄器官特异性毒性标准。
- 预防和治疗考量可参考本声明针对儿童、青少年及年轻成人患者的推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Sinusoidal obstructive syndrome, also known as hepatic veno-occlusive disease, is a potentially life-threatening complication that occurs in children undergoing haemopoietic stem-cell transplantation (HSCT). Differences in the incidence of genetic predisposition and clinical presentation of sinusoidal obstructive syndrome between children and adults have rendered the historical Baltimore and Seattle diagnostic criteria insufficient for children. In 2017, the European Society for Blood and Marrow Transplantation (EBMT) proposed the first paediatric diagnostic and severity grading guidelines for sinusoidal obstructive syndrome, intended for implementation across European centres. However, universally accepted paediatric criteria are needed to ensure prompt diagnosis, definitive treatment, and improved outcomes for children, adolescents, and young adults with sinusoidal obstructive syndrome, and to facilitate international clinical research collaboration. We convened an international panel of multidisciplinary experts including physicians with expertise in HSCT, paediatric intensive care, nephrology, hepatology, radiology, pathology, and transfusion medicine; HSCT advanced-practice providers and medical trainees; pharmacists; and translational and basic science researchers from the Pediatric Acute Lung Injury and Sepsis Investigators Network, the EBMT, the Pediatric Blood and Marrow Transplant Consortia, and several other institutions with extensive experience in sinusoidal obstructive syndrome. Panellists convened at The University of Texas, MD Anderson Cancer Center (Houston, TX, USA) in February, 2019, to evaluate the available evidence. In this expert position statement paper, we provide consensus recommendations for the international implementation of guidelines for the diagnosis, severity grading, and treatment of sinusoidal obstructive syndrome among children, adolescents, and young adults. We endorse universal adoption of paediatric diagnostic guidelines for sinusoidal obstruction syndrome as proposed by the EBMT, and provide implementation guidance for standardisation across centres; we have further proposed adjunctive use of age-appropriate organ-specific toxicity criteria for severity grading and provided prophylaxis and treatment considerations among children and adolescent and young adult patients. Key recommendations include: (1) liver biopsy, portal venous wedge pressure, and reversal of portal venous flow on Doppler ultrasonography should not be used for the routine diagnosis of sinusoidal obstructive syndrome in children, adolescents, and young adults; (2) platelet refractoriness can be defined as a corrected count increment of less than 5000-7500 following at least two sequential ABO-compatible fresh platelet transfusions; (3) hepatomegaly is best defined as an absolute increase of at least 1 cm in liver length at the midclavicular line; and if a baseline measurement is not available, hepatomegaly can be defined as greater than 2 SDs above normal for age; and (4) the presence and volume of ascites can be categorised as mild (minimal fluid by liver, spleen, or pelvis), moderate (<1 cm fluid), or severe (fluid in all three regions with >1 cm fluid in at least two regions).
引用
- Mahadeo KM, Bajwa R, Abdel-Azim H, et al. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol. 2019. PMID: 31818728. doi:10.1016/S2352-3026(19)30201-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。